Dr. Nathan Ledeboer, PhD, D(ABMM)
Associate Professor of Pathology: Medical Director, Clinical Microbiology and Molecular Diagnostics
Medical College of Wisconsin
Dr. David Nicolau, PharmD, FCCP, FIDSA
Director, Center for Anti-Infective Research and Development
As lab testing technologies, infection control policies, and reporting metrics have evolved over the years, the diagnosis of C. difficile infections has remained a vexing and often controversial topic. Recently updated clinical practice guidelines from IDSA/SHEA attempt to shed new light on a familiar debate, but some of the same challenges remain. This webinar presents expert perspectives from two different areas of clinical practice, with commentary on lab testing dilemmas, antimicrobial stewardship, LabID reporting, and the impact of the new guidelines on current practice.